Combining 123 I-Metaiodobenzylguanidine SPECT/CT and 18 F-FDG PET/CT for the Assessment of Brown Adipose Tissue Activity in Humans During Cold Exposure

Abstract:Brown adipose tissue (BAT) has become a focus of research in the hope of finding a new target to fight obesity. Metabolic BAT activity can be visualized with 18 F-FDG PET/CT. Furthermore, the sympathetic innervation of BAT can be visualized with the radiolabeled norepinephrine analog 123 I-metaiodobenzylguani-dine ( 123 I-MIBG). We aimed to determine whether 123 I-MIBG SPECT/CT and 18 F-FDG PET/CT identify the same anatomic regions as active BAT in adult humans. Furthermore, we investigated whether the magnitude of BAT activity measured by these techniques correlated. Finally, we tried to establish the optimal time interval between 123 I-MIBG administration and subsequent SPECT/CT acquisition to visualize sympathetic stimulation of BAT. Methods: Ten lean (body mass index, 19 – 25 kg/m 2 ), healthy Caucasian men (age, 18 – 32 y) underwent one 18 F-FDG PET/CT and two 123 I-MIBG-SPECT/CT scans within a 2-wk interval. On 2 separate occasions, the subjects were exposed to mild cold (17 (cid:1) C) for 2 h after an overnight fast. After 1 h of cold exposure, 18 F-FDG (one occasion) or 123 I-MIBG (other occasion) was administered. 18 F-FDG PET/CT was performed at 1 h after 18 F-FDG administration, and 123 I-MIBG-SPECT/CT was performed at 4 and 24 h after 123 I-MIBG injection. Results: 18 F-FDG uptake in BAT was observed in 8 of 10 subjects, whereas 123 I-MIBG uptake was observed in 7 of 10 subjects in both the SPECT/CT scans acquired at 4 h after 123 I-MIBG administration and the SPECT/CT scans acquired at 24 h after 123 I-MIBG administration. All subjects who showed 123 I-MIBG uptake in BAT also showed 18 F-FDG uptake in BAT. There was no statistically significant correlation between maximal standardized uptake value of 18 F-FDG and semiquantitative uptake of 123 I-MIBG at 4 h after administration. However, a positive correlation was found between the maximal standardized uptake value of 18 F-FDG and semiquantitative uptake of 123 I-MIBG at 24 h after administration ( r 5 0.64, P 5 0.04). Conclusion: 123 I-MIBG SPECT/CT, as a marker of sympathetic activity, and 18 F-FDG PET/CT, as a marker of metabolic activity, identified the same anatomic regions as active BAT. Moreover, when 123 I-MIBG SPECT/CT was performed at 24 h after 123 I-MIBG administration, the magnitude of BAT activity measured with these techniques correlated strongly. This finding not only supports that BAT activity in humans is sympathetically influenced but also identifies 123 I-MIBG SPECT/CT, when performed 24 h after 123 I-MIBG injection, as a method to visualize and quantify sympathetic stimulation of BAT.

Medicine,Environmental Science